Stocks · News reference
Micron Biomedical has appointed Dr. Anand Subramony as Executive Vice President of Global Product Development and Combination Product Commercialization.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
SK Hynix surged 13.30% on October 28, 2026, following record Q3 results with a sevenfold jump in operating profit and an 80% operating margin. The memory chipmaker's strong performance was driven by robust AI-memory demand, with DRAM and HBM production effectively sold out through 2029. Peers Micron Technology and SanDisk also rallied on the positive sentiment around AI-memory demand.
Nvidia and Micron have benefited significantly from the AI infrastructure spending boom, with record revenues driven by demand for AI chips and memory. However, both stocks face substantial downside risk if tech giants reduce their AI investments. Nvidia's growth is heavily dependent on continued data center spending, while Micron operates in a cyclical memory business vulnerable to supply-demand imbalances. If AI spending slows, Nvidia appears better positioned to weather the downturn.
Micron Technology stock surged 4.8% after rival SK Hynix reported record quarterly results and announced that memory chip demand will outpace supply through 2030, with supply sold out for the next three years. As one of the Big Three memory chipmakers, Micron stands to benefit from continued strong demand for AI-related memory chips, with the stock trading at an attractive 13x earnings despite 340% gains over the past year.